These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14093105)

  • 21. [CLINICO-EXPERIMENTAL RESEARCH ON A NEW PLASMA SUBSTITUTE].
    CAVAZZA F; CATANZARITI G
    Minerva Anestesiol; 1963 Sep; 29():402-7. PubMed ID: 14093120
    [No Abstract]   [Full Text] [Related]  

  • 22. The metabolic response of the liver when acute experimental haemorrhagic shock is treated with dextran or gelatin-type plasma expanders.
    Hollmén A; Pihlajaniemi R; Reinilä M; Ryhänen P
    Ann Chir Gynaecol Fenn; 1972; 61(3):173-80. PubMed ID: 4639243
    [No Abstract]   [Full Text] [Related]  

  • 23. BLOOD VISCOSITY ALTERATION FOLLOWING HEMORRHAGE AND AFTER VOLUME RESTITUTION WITH SALINE, PLASMA, DEXTRANS, OR SHED BLOOD.
    HOYT RK; DOMANIG E; HAHNLOSER P; DELIN NA; SCHENK WG
    Surg Forum; 1964; 15():34-5. PubMed ID: 14189402
    [No Abstract]   [Full Text] [Related]  

  • 24. THE PHYSIOLOGIC PROPERTIES OF GLYCO-ALGINATE, A NEW JAPANESE PLASMA-VOLUME EXPANDER.
    MURPHY GP; MUNDY RL; EWALD RA
    Surgery; 1964 Dec; 56():1099-108. PubMed ID: 14238365
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood viscosity, erythrocyte aggregation, and recovery from an experimental hemorrhagic shock.
    Lundsgaard-Hansen P; Marti B
    Vox Sang; 1972; 22(2):107-19. PubMed ID: 5013239
    [No Abstract]   [Full Text] [Related]  

  • 26. Study on alterations of blood flow and blood viscosity under hemorrhagic shock and effects of plasma expander.
    Matsunaga Y
    Nagoya J Med Sci; 1969 Mar; 31(3):339-55. PubMed ID: 5772253
    [No Abstract]   [Full Text] [Related]  

  • 27. [Shock problems and blood replacement with special reference to the expander problem].
    Hässig A
    Anaesthesist; 1966 Aug; 15(8):271-6. PubMed ID: 4871091
    [No Abstract]   [Full Text] [Related]  

  • 28. [CONSIDERATIONS ON PLASMA SUBSTITUTES. CLINICAL FINDINGS CONCERNING A NEW GELATIN DERIVATIVE].
    FERRABOSCHI P; GALLI P; CARASSAI P
    Biol Lat; 1964; 17():187-96. PubMed ID: 14265770
    [No Abstract]   [Full Text] [Related]  

  • 29. [CLINICAL INDICATIONS FOR THERAPY WITH POLYMERIZED GELATIN BREAKDOWN PRODUCTS IN PREPARATION FOR SURGERY IN PATIENTS IN ESPECIALLY POOR CONDITION].
    BUSCIONI-FRANCALANCI G; MONTI G
    Minerva Anestesiol; 1963 Sep; 29():394-8. PubMed ID: 14093118
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of intravascular volume deficiency. Clinical experience report on Haemaccel].
    Schäfer H
    Med Klin; 1967 Dec; 62(51):1992-5. PubMed ID: 5595353
    [No Abstract]   [Full Text] [Related]  

  • 31. Gelatin solution as a plasma substitute in the treatment of shock from acute blood loss.
    FELMUS LB
    Am J Surg; 1949 Sep; 78(3):374-8. PubMed ID: 18139059
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of plasma substitutes (dextran, polyvinylpyrrolidone and oxypolygelatin) with saline therapy in treatment of experimental tourniquet and burn shock in mice.
    MILLICAN RC; STOHLMAN EF; MOWRY RW
    Am J Physiol; 1952 Jul; 170(1):173-8. PubMed ID: 12985881
    [No Abstract]   [Full Text] [Related]  

  • 33. [CURRENT STATUS OF THERAPY WITH PLASMA SUBSTITUTES].
    BIGAZZI PL
    Minerva Anestesiol; 1963 Sep; 29():319-28. PubMed ID: 14093104
    [No Abstract]   [Full Text] [Related]  

  • 34. Responses to hemorrhage replaced by lactated Ringer solution.
    Boba A
    Acta Anaesthesiol Scand Suppl; 1968; 31():5-76. PubMed ID: 4952984
    [No Abstract]   [Full Text] [Related]  

  • 35. [DIURESIS AND RENAL HEMORRHAGE IN HEMORRHAGIC SHOCK AND AFTER TRANSFUSION].
    HORHERR V
    Gynaecologia; 1963; 156():345-58. PubMed ID: 14087546
    [No Abstract]   [Full Text] [Related]  

  • 36. Traumatic brain injury attenuates the effectiveness of lactated Ringer's solution resuscitation of hemorrhagic shock in rats.
    Yuan XQ; Wade CE
    Surg Gynecol Obstet; 1992 Apr; 174(4):305-12. PubMed ID: 1553610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fundamentals in the therapy of hemorrhagic-traumatic shock conditions using plasma substitutes].
    Lundsgaard-Hansen P
    Schweiz Med Wochenschr; 1968 Aug; 98(34):1273-81. PubMed ID: 5682776
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of plasma substitute solutions on the respiratory function of the blood in hemorrhagic shock of rabbits in the state of wakefulness].
    Knorpp K; Bauer C; Rathschlag-Schaefer AM; Bartels H
    Arzneimittelforschung; 1970 Jun; 20(6):853-6. PubMed ID: 5468903
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the efficacy of nonspecific bovine plasma in the treatment of hemorrhagic shock].
    BEAULNES A; TETREAULT L; BORDUAS A
    Rev Can Biol; 1962 Mar; 21():47-50. PubMed ID: 13866204
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental and clinical experience with the therapeutic use of fibrinolysis in hemorrhagic shock.
    Encke A; Lasch HG
    J Cardiovasc Surg (Torino); 1967; 8(2):167-70. PubMed ID: 4225892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.